Governance and AIDS in AfricaANRSEBOKO
Transcription
Governance and AIDS in AfricaANRSEBOKO
Proposal “Governance and AIDS in Africa: universal access, national differences. Limits, obstacles, perspectives”. (CI ANRS 12 251) Coordination : M. Enguéléguélé (IAG Dakar & F. Eboko (IRD, UMR 912 Marseille) The Governance Group Presentation Fred EBOKO, IRD UMR 912 SE4S IRD – INSERM – Université Aix Marseille. France [email protected] Africa in a global view 22.5 million people living with HIV in Africa, 2009 Outline Brief Introduction : what “governance” means? I. History of AIDS responses in Africa : from tragedy to Scaling Up II. Issues for an analytical framework III. Mapping a collective and interdisciplinary proposal For an operational research IV. The governance group Background What Governance means? To manage resources Who governs AIDS policies in Africa? Hypothesis : Expertise mobilization does not mean lack of skills Policies Networks versus Politics For instance, the skills/expertise turn over in countries represents a legal barrier for implementation of AIDS policies Objective of our project: reduce the gap between policies and politics by the implementation of “Governance Networks” I – History An international Aid Community : from coordination to “Polyarchy” From GPA to UNAIDS The Global Fund vs the PEPFAR : Multilateralism vs Bilateralism ? Unitaid as a new funding mechanism International Foundations (Clinton, Bill & Melinda Gates) The African States and the AIDS Crisis II – Issues for an analy;cal framework From intimacy to politics Who governs? o A Comparative Approach Burkina Faso Cameroon Côte d’Ivoire Senegal o A Global Response, National Experiences. Universal Access : Issues and Challenges II/2 Pays Taux de séroprévalence au VIH/sida (Année) Pourcentage d'adultes et d'enfants dont l'infection à VIH est parvenue à un stade avancé de sida qui reçoivent des antirétroviraux (2009) Cameroun 5.1% (2005) – 7.5% (2009) 46.4% Sénégal 0.7% (2009) 75.6% Burkina Faso 2% (2008) 47% Côte d’Ivoire 3.8% (2008) 31% (2007) Source : UNGASS 2010, UNAIDS 2008 II/3 Research questions : policies vs politics? ‐ Actors: networks, experts and policy brokers ‐ Ideas : advocacy coalitions ‐ E.g. “best practices”, guidelines, etc. ‐ Policy instruments and power ‐ Implementation of AIDS/Health Policy in each country . Diachronic and synchronic analysis ‐ Link or gap between epidemiological dynamics and policies Specific Groups (OVC/OEV, MSM/ HSH, Road transport workers, Sex workers, etc.) III – Methodology and Framework Mapping a collective and interdisciplinary proposal International level : Global Fund in a Global Challenge : lessons from Crisis (Economic Crisis, 2008) For an operational research The Global Fund : Inputs from an international strategy • 2001: An international and multilateral response, Kofi Annan’s «War Treasure » • An idea whose time had come • Catalyzed African leadership • 2002 Launched at G8 Summit in Okinawa • GFTAM Funding Rounds: from hope to constraints 1 additional proposal : • Dr Louis Pizarro (MD, PhD proposal in Public Health. Dir. Pr Jean‐Paul Moattî A “Story Funding” approach : Senegal Burkina Faso, Cameroon, Côte d’Ivoire? Who pays? Bureaucracy organization and power : Who Governs A second Proposal in addition : Elise Demange “Country Coordinating Mechanisms” as a policy instrument : Senegal and Cameroon The Governance Group Africa Burkina Faso : Groupe de Recherches sur les Politiques Locales (GRIL, Université de Ouagadougou) Senegal : Africa Governance Institute, Dakar Cameroon : Fondation Paul Ango Ela pour la géopolitique en Afrique Centrale (FPAE, Yaounde) Côte d’Ivoire : PAC CI + Aconda + CERAP (?) France UMR 912 SE4S Marseille, Univ. de Lille 2/IUF, CEPED • Political Science (8) • Political Economy / Economics (3) • Anthropology ‐ Sociology ‐ Demography(6) • • Public Health (3 + 2) • International organizations Thank you for your kind aFen;on
Documents pareils
Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis
severe AIDS-defining and non-AIDS-defining morbidity. While the diseases that might
justify earlier initiation in high-income countries are generally non-infectious (nonAIDS-defining malignancies, ...